Chad R. Baker’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-25,470
Closed -$3.23M 53
2021
Q3
$3.23M Hold
25,470
0.72% 39
2021
Q2
$4.24M Hold
25,470
0.95% 37
2021
Q1
$4.63M Hold
25,470
1.11% 34
2020
Q4
$5.09M Sell
25,470
-530
-2% -$108K 1.24% 30
2020
Q3
$5.7M Sell
26,000
-3,000
-10% -$635K 1.54% 30
2020
Q2
$5.54M Sell
29,000
-8,035
-22% -$1.41M 1.67% 26
2020
Q1
$5.74M Sell
37,035
-9,310
-20% -$1.08M 2.23% 22
2019
Q4
$3.88M Hold
46,345
1.29% 33
2019
Q3
$3.14M Hold
46,345
1.12% 35
2019
Q2
$3.08M Hold
46,345
1.07% 36
2019
Q1
$2.58M Hold
46,345
0.93% 39
2018
Q4
$2.3M Hold
46,345
0.99% 38
2018
Q3
$4M Hold
46,345
1.46% 32
2018
Q2
$2.69M Buy
+46,345
New +$2.26M 1.08% 36

Other funds holding TDOC

Chad R. Baker's TDOC Position: Q4 2021 in Review

Chad R. Baker sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 25,470 shares — an estimated $3.23M sold.

Chad R. Baker first reported a position in TDOC in Q2 2018 and held it in 14 quarters. The position peaked at $5.74M in Q1 2020. 728 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Chad R. Baker reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Chad R. Baker sold 25,470 Teladoc Health shares in Q4 2021, an estimated $3.23M.
  • Chad R. Baker first reported a position in Teladoc Health in Q2 2018 and held it in 14 quarters.
  • Chad R. Baker's Teladoc Health position peaked at $5.74M in Q1 2020.
  • 728 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Chad R. Baker's 13F filing for Q4 2021, filed 8 Feb 2022.